Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

With Abstral Launch, Galena Makes its Opening Gambit

Galena Biopharma Inc. (Nasdaq: GALE) yesterday announced the official product launch of Abstral, a "breakthrough-pain" drug for cancer patients that the Portland-based biotech believes will help finance development of its promising breast-cancer vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK